Ben Lakey

MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

14 unicorns later (12 from seed rounds), Cindy is ready to launch a $50M fund II to invest in the best founders from preseed/seed via CapitalX! https://angel.co/v/l/sb1cv CapitalX is well positioned to bring enhanced access to LPs and amplified support to founders.

Syndi Health offers an all-in-one platform for aggregating, recommending, and paying for digital health services. The platform simplifies the procurement process, enabling organisations to deliver tailored and clinically proven services to their employees. With a focus on personalised health solutions, Syndi Health aims to improve health outcomes and optimise return on investment for organisations. For more information about Syndi Health, visit https://www.syndihealth.com.

MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

Mitt Prostheses was founded to build prosthetic bionic limbs at affordable prices for those who need them. What we have designed is an incredibly comfortable, highly functional prosthetic arm. One that the user can fit to themselves in seconds instead of waiting weeks for clinicians. All at a price that is actually affordable. More information on product development and preference trials can be found on our website www.WearMitt.com and twitter @WearMitt.